Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | ELANE | P08246 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | PLG | P00747 | 1/20 | 0.47 |
| ▸ | RXRA | P19793 | 1/20 | 0.46 |
| ▸ | RXRB | P28702 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.46 |
| ▸ | KLK1 | P06870 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12154217 | 0.88 | ALDH1A1 (0.57) | MAPTKDM4ELMNAHSP90AA1RECQL | |
| SCHEMBL12154283 | 0.88 | ALDH1A1 (0.57) | MAPTKDM4ELMNAHSP90AA1RECQL | |
| SCHEMBL26832415 | 0.88 | ALDH1A1 (0.57) | MAPTKDM4ELMNAHSP90AA1RECQL | |
| SCHEMBL12199916 | 0.88 | ALDH1A1 (0.57) | MAPTKDM4ELMNAHSP90AA1RECQL | |
| SCHEMBL29993865 | 0.85 | MAPT (0.51) | MAPTKDM4ELMNAHSP90AA1RECQL | |
| SCHEMBL25491843 | 0.83 | MAPT (0.58) | MAPTKDM4ELMNAHSP90AA1POLB | |
| SCHEMBL12199956 | 0.83 | TP53 (0.52) | MAPTKDM4ELMNAHSP90AA1RECQL | |
| SCHEMBL12154284 | 0.83 | TP53 (0.59) | MAPTKDM4ELMNAHSP90AA1RECQL | |
| SCHEMBL26832413 | 0.83 | TP53 (0.59) | MAPTKDM4ELMNAHSP90AA1RECQL | |
| SCHEMBL11550359 | 0.83 | TP53 (0.59) | MAPTKDM4ELMNAHSP90AA1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455061-B2 | Optically active compound having polymerizable group and its polymer | JNC CORPORATION (JP) | 2013-06-04 | — | — | US | disclosed |
| US-8404316-B2 | Polymerizable liquid crystal compound and its polymer | JNC CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| US-8366962-B2 | Polymerizable liquid crystal compounds having oxiranyl group, polymerizable liquid crystal compositions and polymers | JNC CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20110240918-A1 | OPTICALLY ACTIVE COMPOUND HAVING POLYMERIZABLE GROUP AND ITS POLYMER | CHISSO CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110147656-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS HAVING OXIRANYL GROUP, POLYMERIZABLE LIQUID CRYSTAL COMPOSITIONS AND POLYMERS | CHISSO CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CHISSO CORPORATION (JP) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CCNT1, POF1B, CCND3 | MAPT 2658/4885KDM4E 4051/4885LMNA 2223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.